Commerzbank takes €111m of XVA losses in H1

Adjustments to the valuation of derivatives (XVAs) cost Commerzbank €111 million ($132 million) over the first six months of the year. A year ago, these added €71 million to revenues.

Credit, debit and funding valuation adjustments (CVA, DVA and FVA) took €160 million out of first-quarter income as credit spreads widened, elevating the risk of counterparty defaults and pumping up the cost of funding margin payments. These same adjustments added €49 million to second-quarter income, though, as

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: